Increased sensitivity of prediabetic nonobese diabetic mouse to the behavioral effects of IL-1

被引:16
作者
Bluthé, RM
Jafarian-Tehrani, M
Michaud, B
Haour, F
Dantzer, R
Homo-Delarche, F
机构
[1] INRA, INSERM U394, Inst Francois Magendie, F-33077 Bordeaux, France
[2] NIMH, Clin Neuroendocrinol Branch, Bethesda, MD 20892 USA
[3] Hop St Antoine, INSERM U339, F-75571 Paris, France
[4] Univ Paris 05, Hop Necker, CNRS URA 1461, F-75015 Paris, France
关键词
NOD mouse; stress; infection; interleukin-1 (IL-1); brain IL-1 receptors; behavior;
D O I
10.1006/brbi.1998.0542
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The nonobese diabetic (NOD) mouse is a model of spontaneous insulin-dependent diabetes mellitus (IDDM) or type I diabetes. In humans, and in animal models of IDDM, the progression of the disease is modulated by various environmental factors, particularly infectious agents. Interleukin-1 (IL-1) plays a pivotal role in the development of IDDM, and modulation of its synthesis may be a mechanism by which environmental modulation of disease progression occurs. Since various alterations at the level of the gene, number, and sensitivity of IL-1 receptors have been described in different animal models of autoimmune disease, we investigated, in the prediabetic NOD mouse, the presence of IL-1 receptors and their functional behavioral characteristics. Here we present evidence that prediabetic NOD mice exhibit a normal distribution and density of functional brain IL-1 receptors, but are more sensitive to the behavioral effects of IL-1 than the control ICR strain. (C) 1999 Academic Press.
引用
收藏
页码:303 / 314
页数:12
相关论文
共 63 条
[1]   GROUP-SIZE, CAGE SHELF LEVEL, AND EMOTIONALITY IN NONOBESE DIABETIC MICE - IMPACT ON ONSET AND INCIDENCE OF IDDM [J].
ADER, DN ;
JOHNSON, SB ;
HUANG, SW ;
RILEY, WJ .
PSYCHOSOMATIC MEDICINE, 1991, 53 (03) :313-321
[2]  
AMRANI A, 1995, EUR CYTOKINE NETW, V6, P103
[3]   Interleukin-1 effect on glycemia in the non-obese diabetic mouse at the pre-diabetic stage [J].
Amrani, A ;
JafarianTehrani, M ;
Mormede, P ;
Durant, S ;
Pleau, JM ;
Haour, F ;
Dardenne, M ;
HomoDelarche, F .
JOURNAL OF ENDOCRINOLOGY, 1996, 148 (01) :139-148
[4]  
ATKINSON MA, 1994, NEW ENGL J MED, V331, P1428
[5]   INSULIN-DEPENDENT DIABETES-MELLITUS AS AN AUTOIMMUNE-DISEASE [J].
BACH, JF .
ENDOCRINE REVIEWS, 1994, 15 (04) :516-542
[6]   RECEPTORS FOR INTERLEUKIN-1 (ALPHA AND BETA) IN MOUSE-BRAIN - MAPPING AND NEURONAL LOCALIZATION IN HIPPOCAMPUS [J].
BAN, E ;
MILON, G ;
PRUDHOMME, N ;
FILLION, G ;
HAOUR, F .
NEUROSCIENCE, 1991, 43 (01) :21-30
[7]   Human type 1 diabetes and the insulin gene: Principles of mapping polygenes [J].
Bennett, ST ;
Todd, JA .
ANNUAL REVIEW OF GENETICS, 1996, 30 :343-370
[8]   CHARACTERIZATION OF POLYMORPHISMS OF AN INTERLEUKIN-1 RECEPTOR-TYPE-1 GENE (IL1RI) PROMOTOR REGION (P2) AND THEIR RELATION TO INSULIN-DEPENDENT DIABETES-MELLITUS (IDDM) [J].
BERGHOLDT, R ;
KARLSEN, AE ;
JOHANNESEN, J ;
HANSEN, PM ;
DINARELLO, CA ;
NERUP, J ;
POCIOT, F .
CYTOKINE, 1995, 7 (07) :727-733
[9]   Immune-neuro-endocrine interactions: Facts and hypotheses [J].
Besedovsky, HO ;
DelRey, A .
ENDOCRINE REVIEWS, 1996, 17 (01) :64-102
[10]   Hypersensitivity of lurcher mutant mice to the depressing effects of lipopolysaccharide and interleukin-1 on behaviour [J].
Bluthe, RM ;
Michaud, B ;
DelhayeBouchaud, N ;
Mariani, J ;
Dantzer, R .
NEUROREPORT, 1997, 8 (05) :1119-1122